Business Wire

Visa Growth Corporates Working Capital Index Reveals Rise of the Strategic Planner and Adaptable Accelerator Shaping the Future of Liquidity Management

29.9.2025 08:00:00 CEST | Business Wire | Press Release

Share

Visa (NYSE:V), a global leader in digital payments, today released findings from its third annual Growth Corporates Working Capital Index, based on insights from more than 1,400 CFOs and Treasurers across 10 industries and 23 countries. The data reveals a pivotal shift in how mid-sized companies around the world are approaching financial strategy: working capital is no longer just a buffer, but the new growth engine. These organizations are leveraging digital tools, AI, and cards to unlock millions in savings, turning market volatility into strategic advantage.

The research notably highlights two powerful and distinct corporate CFO and Treasurer profiles, whose behaviors are fundamentally redefining the way organizations deploy working capital solutions (WCS) across industries and regions: the Strategic Planner and the Adaptable Accelerator.

Two CFO Profiles Reshaping Corporate Finance

Adaptable Accelerators act decisively to address urgent, short-term needs using working capital solutions to manage volatility, seasonal swings and unexpected shortfalls, or to capture emerging growth opportunities. The use of corporate cards for opportunistic working capital needs has tripled year-over-year globally for this segment, sharp evidence of agility, with finance leaders now 64% more likely than last year to deploy these solutions for unplanned growth. In Asia Pacific, opportunistic WCS usage climbed sharply from 5.6% to 9%, highlighting responsiveness needed in dynamic markets.

Strategic Planners view working capital as a tool for expansion, capital investment and deepening supplier relationships, not merely as a defensive reserve. These experienced finance leaders are 32% more likely than peers to have long tenure and drive sustained value, frequently reinvesting over half of their working capital savings into product and service innovation. North America exemplifies the momentum: firms acting as Strategic Planners nearly doubled in two years (18% to 33%).

“Our 2025-2026 Index underscores that working capital management is no longer defensive,” said Lauren Hewings, Visa’s Head of Working Capital Solutioning. “Finance leaders are unlocking an average of $19 million in savings, while accelerating supplier payments and transforming receivables—and they’re doing it by tapping corporate and virtual cards combined with AI-powered insights, turning working capital into a decisive growth lever.”

Efficiency Gains & Technology Adoption

Middle market organizations are increasingly putting capital to work, unlocking an average of $19M by paying suppliers earlier, negotiating better terms and optimizing inventory management. In 2025, 58% of Growth Corporates leveraged generative and agentic AI for forecasting, workflow automation and supplier onboarding—a move that has contributed to a tripling of cash flow visibility since 2023 and delivered 66% greater savings with these solutions. Europe leads globally in AI adoption for working capital optimization, with 65% of firms now relying on AI-enhanced forecasting and cash management tools. Across regions, Index scores continue to rise: North America climbed from 51% in 2023 to 55% in 2025, while cash flow uncertainty plummeted from 21% to just 3.7%.

Corporate Cards: The Strategic Lever and Accelerator

Delayed receivables continue to cost firms an average of $18M per year, draining growth potential. Now, 53% of CFOs and Treasurers use corporate and virtual cards to reduce Days Sales Outstanding (DSO) and accelerate cash flow, with over 60% of firms in North America and Europe leveraging cards for faster settlements, streamlined workflows and robust transaction data.

Experience and Strategy Go Hand-in-Hand

Veteran CFOs are twice as likely to leverage virtual or corporate cards and 32% more likely to treat working capital solutions as a strategic growth catalyst compared to newer finance leaders. Organizations helmed by Strategic Planners consistently outperform peers on efficiency, resilience and innovation investment.

New Demands from Corporate Finance Leaders

Across regions, companies are calling for:

  • Simplified digital solutions for credit and account management
  • On-demand financing aligned to real-time cash flow cycles
  • AI-powered forecasting and deep sector expertise from finance partners

Loan rejection rates have jumped from 4% to 27% globally, as banks lag on digital-first, tailored offerings, prompting middle-market firms to seek out providers that match their speed, flexibility and digital ambitions.

As corporate CFOs and Treasurers continue to navigate an increasingly complex and volatile financial landscape, the emergence of these distinct behavioral profiles signals a new era of working capital management: one marked by intentionality, agility and innovation. By harnessing AI, corporate cards and streamlined digital tools, finance leaders are not only optimizing liquidity but also turning working capital into a powerful driver of growth and resilience.

To read the full report and see how you index against your peers, please visit https://workingcapitalindex.visa.com.

About the Index

Visa’s Growth Corporates Working Capital Index tracks financial behavior among mid-sized firms, defined as companies with annual revenues between $50 million and $1 billion. The 2025-2026 edition is based on survey responses from 1,457 CFOs and Treasurers across 23 countries and 10 industry segments. The Index provides fresh insights into strategy trends, efficiency gains and the evolving behavioral profiles shaping corporate finance, including the emergence of strategic and adaptable working capital users.

About Visa Inc.

Visa (NYSE: V) is a world leader in digital payments, facilitating transactions between consumers, merchants, financial institutions and government entities across more than 200 countries and territories. Our mission is to connect the world through the most innovative, convenient, reliable and secure payments network, enabling individuals, businesses and economies to thrive. We believe that economies that include everyone everywhere, uplift everyone everywhere and see access as foundational to the future of money movement. Learn more at Visa.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250928667994/en/

Contacts

David Thum
dthum@visa.com

(c) 2024 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

OM Pharma to Unveil the Largest Multi-Country Real-World Evidence Study on Broncho‑Vaxom® (OM‑85) for RTI Prevention at EAACI 202614.6.2026 10:00:00 CEST | Press Release

OM Pharma will reveal preliminary results from the REACH study at the European Academy of Allergy and Clinical Immunology (EAACI) Congress. REACH is the first and largest multi-country real-world evidence (RWE) study to date evaluating the impact of Broncho-Vaxom® in patients with recurrent respiratory tract infections (RTIs).1,2 The findings offer critical new clinical evidence of the therapy's effectiveness in everyday clinical practice. In a real-world cohort of 15,794 paediatric (aged >1 year), adolescent, adult and elderly patients in China, Italy, and Belgium, Broncho-Vaxom® was associated with reductions in RTI recurrence and healthcare utilisation at 12 and 24 months after treatment initiation, compared with the 12 months prior to starting the therapy.1 “The REACH real-world evidence study shows that Broncho-Vaxom® can significantly reduce infections requiring medical visits across age groups and co-morbidities,” said Anna Thomas, Chief Scientific Officer at OM Pharma. “Recurre

Incyte Announces New Positive Data at EHA 2026 Showed INCA033989 Achieved Rapid, Robust and Sustained Clinical and Molecular Responses and Was Well Tolerated in Patients with Myelofibrosis and Essential Thrombocythemia13.6.2026 17:15:00 CEST | Press Release

Incyte (Nasdaq:INCY) today announced updated clinical data from two Phase 1 studies evaluating the safety, tolerability and efficacy of INCA033989, a first-in-class mutant calreticulin (mutCALR)-targeted monoclonal antibody, in patients with mutCALR-expressing myeloproliferative neoplasms (MPNs). INCA033989 demonstrated rapid, clinically meaningful responses and consistent molecular activity across both myelofibrosis (MF) and essential thrombocythemia (ET), with convergent evidence supporting the potential for disease modification. These findings are being presented in oral and poster presentations at the European Hematology Association (EHA) 2026 Congress in Stockholm, Sweden (Session: Myeloproliferative neoplasms – Clinical, Presentation numbers: S216, PS1983, PF884). “The data presented at EHA 2026 demonstrate clinically meaningful and consistent responses with INCA033989 across both myelofibrosis and essential thrombocythemia,” said Pablo J. Cagnoni, M.D., President of Incyte and G

Results from Incyte’s Pivotal Phase 3 frontMIND Trial of Tafasitamab (Monjuvi ® /Minjuvi ® ) Combination Presented at the 2026 European Hematology Association (EHA) Congress Plenary Showed Prolonged Progression Free Survival13.6.2026 12:00:00 CEST | Press Release

Incyte (Nasdaq:INCY) today announced positive results from the pivotal Phase 3 frontMIND trial evaluating the efficacy and safety of tafasitamab (Monjuvi®/Minjuvi®), a humanized Fc-modified cytolytic CD19-targeting monoclonal antibody, and lenalidomide added to R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone; Tafa-Len-R-CHOP) versus R-CHOP, the current standard of care, as a first-line treatment for adults with previously untreated diffuse large B-cell lymphoma (DLBCL) or high-grade B-cell lymphoma (HGBL). Eligible patients had an International Prognostic Index (IPI) score of 3-5, or, for patients ≤60 years of age, an age-adjusted IPI (aaIPI) of 2-3. These data are being highlighted in a prestigious Plenary Abstracts Session at the European Hematology Association (EHA) 2026 Congress, being held June 11 - 14, 2026, in Stockholm, Sweden (Abstract # S101. Plenary Abstract Session. June 13, 6:00 - 7:30 a.m. ET [12:00-1:30 p.m. CEST]). frontMIND results were als

Charlotte Tilbury awarded CBE in the King’s Birthday Honours 202612.6.2026 23:31:00 CEST | Press Release

Charlotte Tilbury CBE, sole Founder, President, Chairman and Chief Creative Officer of Charlotte Tilbury Beauty, has been awarded a Commander of the Order of the British Empire (CBE) in the King’s Birthday Honours 2026 for services to the beauty and cosmetics industry. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260612679101/en/ Charlotte Tilbury, founder, president, chairman and chief creative officer of Charlotte Tilbury Beauty, who has been awarded a CBE (Commander of the Order of the British Empire) in 2026 for services to the beauty industry and entrepreneurship. (Photo: Charlotte Tilbury team) This honour recognises Charlotte’s contribution to leading and building Britain’s most successful global beauty brand. She has played a defining role in revolutionising the beauty industry and driving economic growth of the UK beauty sector, which has expanded from approximately £17bn in 2013 to over £31bn today. Charlotte Til

IQM Appoints Barbara Venneman, Vanguard Board Director and Former Global Head of Deloitte Digital, to its Board of Directors12.6.2026 18:36:00 CEST | Press Release

IQM Quantum Computers, the global leader in superconducting quantum computers, today announced the appointment of Barbara Venneman to its Board of Directors. Venneman deepens the Board's expertise in digital transformation, enterprise technology commercialization, and global business scaling as IQM expands its commercial footprint worldwide. Additionally, CEO and Co-founder Jan Goetz will replace Co-founder Juha Vartiainen as the Founder representative on the IQM Board. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260612650938/en/ IQM Appoints Barbara Venneman, Vanguard Board Director and Former Global Head of Deloitte Digital, to its Board of Directors Ms. Venneman joins the IQM Board of Directors following a distinguished career at the intersection of advanced technology, strategy, and business transformation. She most recently served as Global Head of Deloitte Digital and previously held senior global leadership roles,

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye